Dispatches from FIE 2011

Beneo: “We need to have a new future now”

By Shane Starling from Paris

- Last updated on GMT

Related tags: European commission, European parliament, European union

Today the European Commission meets to decide whether or not to send the controversial European Union health claims register to the European Parliament – now is no time to abort the process says European ingredients giant, Beneo.

With just 20% of more than 2500 health claim applications approved, voices are rising to halt a despised, claim-curtailing process before it does any further damage to the European food and supplements industries.

But one of Europe and the world’s largest ingredient suppliers, the Beneo Group, says stalling now will benefit no one. Even though the list is deeply flawed, it is time to move forward and make law what has for so long been ambiguous, the company’s vice president of regulatory affairs and nutrition communication, Anke Sentko, told NutraIngredients at Food Ingredients Europe in Paris last week.

“For more than two years now we monitored that innovation power is going down…you have no progress – you have no real future,”​ Sentko reasoned. “This is what we need to stop. We need to go ahead – we need to have a new future now.”

“New research may come as well. It is now much more clear what EFSA is expecting. The guidelines are there so you know what to measure. You can at least work with new article 13.5 claims and go ahead with that.”

Related news

Show more

Related products

show more

A Promising Product for Comprehensive Men's Health

A Promising Product for Comprehensive Men's Health

Chemical Resources (CHERESO) | 17-Jun-2019 | Clinical Study

Testosterone deficiency is increasingly recognized as a significant health problem in men. Testosterone deficiency can adversely affect sexual function,...

Fermented Soy for Natural Digestive Support

Fermented Soy for Natural Digestive Support

Lallemand Bio-Ingredients | 22-Apr-2019 | Technical / White Paper

Lallemand is running a new clinical trial for Gastro-AD® in spring 2019. Gastro-AD® is a clinically studied food supplement based on non-GMO soy fermented...

Related suppliers

Follow us

Featured Events

View more


View more